Jordan Graff, MD
Retina Specialist · Phoenix, AZNPI 1952487829
Payments from drug & device makers
Across 784 payments — averaging $5653.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$3.7M
- Genentech USA, Inc.$254K
- Kyowa Kirin, Inc.$186K
- F. Hoffmann-la Roche AG$64K
- Roche TCRC, Inc.$62K
- Roche Products Limited$40K
- plus $94K from 22 others
Across 28 payments — averaging $1957.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$35K
- Genentech, Inc.$20K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 316 | $3,732,509 |
| Genentech USA, Inc. | 217 | $253,733 |
| Kyowa Kirin, Inc. | 63 | $186,329 |
| F. Hoffmann-la Roche AG | 24 | $64,132 |
| Roche TCRC, Inc. | 8 | $61,969 |
| Roche Products Limited | 7 | $40,189 |
| AbbVie(2 entities) | 13 | $18,841 |
| Regeneron | 12 | $15,892 |
| Ocular Therapeutix, Inc. | 8 | $14,295 |
| Regeneron Healthcare Solutions, Inc. | 33 | $10,852 |
| Astellas Pharma Global Development | 1 | $7,793 |
| Apellis Pharmaceuticals, Inc. | 16 | $7,503 |
| Hoffmann-la Roche Limited | 2 | $7,265 |
| Alimera Sciences, Inc. | 15 | $6,243 |
| Harrow Eye, LLC | 2 | $3,500 |
| Novartis | 15 | $706 |
| Astellas Pharma US Inc | 9 | $226 |
| Biogen | 5 | $180 |
| Bausch & Lomb Americas Inc. | 6 | $121 |
| Sight Sciences, Inc. | 1 | $116 |
| Eyepoint US, Inc. | 1 | $49 |
| Rayner Intraocular Lenses Limited | 2 | $47 |
| Aerie Pharmaceuticals, Inc. | 2 | $37 |
| Alcon | 2 | $37 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $18 |
| Kala Pharmaceuticals, Inc. | 1 | $16 |
| Coherus Oncology, Inc. | 1 | $15 |
How this compares
$4,432,630 in reported general payments places this provider in the 95th percentile of 30 retina specialist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Phoenix
- Henry KwongPhoenix$3.4M
- Alan GordonPhoenix$1.2M
- Stephen de SouzaPhoenix$952K
- Rahul ReddyPhoenix$581K
- Benjamin BakallPhoenix$533K
- Suhail AlamPhoenix$476K
- Jack SipperleyPhoenix$409K
- Joseph BryanPhoenix$199K
- Jaime GaitanPhoenix$187K
- Rima PatelPhoenix$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.